Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michele Vincitore"'
Autor:
Susan Sheehan, Ann Michelini, David P. Ryan, Jeffrey A. Meyerhardt, Charles S. Fuchs, Peter C. Enzinger, Andrew X. Zhu, Craig C. Earle, Jeffrey W. Clark, Matthew H. Kulke, Michele Vincitore
Publikováno v:
Journal of Clinical Oncology. 24:1892-1897
Purpose To investigate the combination of erlotinib, capecitabine, and oxaliplatin in patients who were previously treated for metastatic colorectal cancer. Patients and Methods Patients were eligible if they had metastatic colorectal cancer that pro
Autor:
David P. Ryan, Jeffrey W. Clark, Keith Stuart, Charles S. Fuchs, Michele Vincitore, Matthew H. Kulke, Peter C. Enzinger, Alona Muzikansky, Ann Michelini
Publikováno v:
Journal of Clinical Oncology. 24:401-406
Purpose Standard, intravenous chemotherapy regimens for neuroendocrine tumors have been associated with limited response rates and significant toxicity. We evaluated the efficacy of an oral regimen of temozolomide and thalidomide in patients with met
Autor:
Peter C. Enzinger, Jeffrey W. Clark, Haesook T. Kim, Jeffrey A. Morgan, Matthew H. Kulke, Thomas J. Lynch, Ann Michelini, Michele Vincitore, Charles S. Fuchs
Publikováno v:
Cancer. 101:934-939
BACKGROUND Treatment with traditional cytotoxic chemotherapy regimens containing streptozocin or dacarbazine has resulted in only marginal benefit for patients with metastatic neuroendocrine tumors. The use of these regimens has been further limited
Autor:
Robert J. Mayer, Mathew H. Kulke, B A Michele Vincitore, Craig C. Earle, Jeffrey W. Clark, David P. Ryan, Keith E. Stuart, Haesook T. Kim, Charles S. Fuchs
Publikováno v:
Cancer. 94:3186-3191
BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examinati
Publikováno v:
Behavioural Pharmacology. 11:437-446
Evidence is mounting that prenatal protein malnutrition affects the physiological properties of the GABAergic neurotransmitter system in rats. To investigate the functional behavioral consequences of these changes, chlordiazepoxide (CDP, a positive m
Autor:
Penny L. Shultz, Jed S. Shumsky, Todd A. Fiacco, Douglas L. Rosene, Michele Vincitore, Janina R. Galler, John Tonkiss
Publikováno v:
Pharmacology Biochemistry and Behavior. 65:105-116
The sensitivity of prenatally protein-malnourished rats to the amnestic properties of the benzodiazepine (BZ) receptor agonist, chlordiazepoxide (CDP), was studied in the male offspring of rats provided with a protein-deficient diet (6% casein) for 5
Autor:
Robert J. Mayer, Charles S. Fuchs, Peter C. Enzinger, Craig C. Earle, Jeffrey W. Clark, Alona Muzikansky, Jeffrey A. Meyerhardt, Matthew H. Kulke, Michele Vincitore, Panos Fidias, David P. Ryan, Andrew X. Zhu, Lawrence S. Blaszkowsky
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 20(3)
Background: Recent studies have examined the addition of docetaxel to fluorouracil and cisplatin in advanced esophagogastric cancer. Patients and methods: We carried out a phase I dose-escalation study of weekly docetaxel, cisplatin, and irinotecan (
Autor:
Ann Michelini, Tanya P. Sengupta, Lindsey R. Baden, Matthew H. Kulke, Abraham B. Schwarzberg, Elizabeth H. Stover, Michele Vincitore
Publikováno v:
Cancer investigation. 25(4)
Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia. We evaluated the incidence of lymphopenia and opportunistic infections during treatment and up to 12 months f
Autor:
Matthew H. Kulke, Peter C. Enzinger, Jeffrey W. Clark, Michele Vincitore, Charles S. Fuchs, Thomas J. Lynch, Bingyan Wu, Ann Michelini
Publikováno v:
Cancer investigation. 24(3)
The combination of epirubicin, cisplatin, and infusional 5-fluorouracil (ECF) currently represents a standard and effective regimen for the treatment of advanced gastroesophageal cancer. The use of doxorubicin as an alternative to epirubicin in the E
Autor:
Michele Vincitore, David P. Ryan, Matthew H. Kulke, Jeffrey W. Clark, Robert J. Mayer, Keith Stuart, Charles S. Fuchs, Haesook T. Kim
Publikováno v:
Cancer investigation. 22(3)
Twenty-one patients with metastatic carcinoid tumors were treated with docetaxel. Although the treatment was well tolerated, no objective radiologic responses were observed. Novel, more effective agents are needed for this disease.Traditional combina